Browsing Tag
tumor microenvironment
2 posts
Can Avacta’s peptide drug conjugates rival ADCs? The next chapter in targeted cancer delivery
Avacta’s peptide drug conjugates could change how we deliver cancer drugs. Find out how they compare to ADCs and what’s next for the UK biotech’s platform.
TME Pharma expands AI-driven drug discovery with Aimed Analytics partnership
TME Pharma, a biotechnology company pioneering therapies that target the tumor microenvironment, has announced a strategic collaboration with…